247 related articles for article (PubMed ID: 29742721)
1. Coexistence of Lambert-Eaton myasthenic syndrome and autoimmune encephalitis with anti-CRMP5/CV2 and anti-GABAB receptor antibodies in small cell lung cancer: A case report.
Li H; Zhang A; Hao Y; Guan H; Lv Z
Medicine (Baltimore); 2018 May; 97(19):e0696. PubMed ID: 29742721
[TBL] [Abstract][Full Text] [Related]
2. Lambert-Eaton Myasthenic Syndrome Complicated by Anti-GABA
Yamada K; Yaguchi H; Ishikawa K; Tanaka D; Oshima Y; Mizushima K; Uwatoko H; Shirai S; Takahashi-Iwata I; Matsushima M; Tanaka K; Yabe I
Intern Med; 2024 May; 63(9):1295-1300. PubMed ID: 37743510
[TBL] [Abstract][Full Text] [Related]
3. Etoposide and immunotherapy can improve the outcome of severe anti-GABAB R encephalitis presenting with delta brush: A case report.
Xiping W; Guomin X; Haifeng W; Qi S; Liping Z
Medicine (Baltimore); 2020 Sep; 99(37):e22087. PubMed ID: 32925748
[TBL] [Abstract][Full Text] [Related]
4. Autoimmune encephalitis positive for both anti-γ-aminobutyric acid B receptor and anticollapsin response-mediator protein 5 antibodies: A case report.
Xia J; Yin X; Zhu M; Cao J; Song X
Medicine (Baltimore); 2018 Jan; 97(3):e9574. PubMed ID: 29504979
[TBL] [Abstract][Full Text] [Related]
5. Paraneoplastic Lambert-Eaton Myasthenic Syndrome With Limbic Encephalitis: Clinical Correlation With the Coexistence of Anti-VGCC and Anti-GABAB Receptor Antibodies.
Cho JJ; Wymer JP
J Clin Neuromuscul Dis; 2017 Dec; 19(2):84-88. PubMed ID: 29189554
[TBL] [Abstract][Full Text] [Related]
6. Small-cell lung cancer, paraneoplastic cerebellar degeneration and the Lambert-Eaton myasthenic syndrome.
Mason WP; Graus F; Lang B; Honnorat J; Delattre JY; Valldeoriola F; Antoine JC; Rosenblum MK; Rosenfeld MR; Newsom-Davis J; Posner JB; Dalmau J
Brain; 1997 Aug; 120 ( Pt 8)():1279-300. PubMed ID: 9278623
[TBL] [Abstract][Full Text] [Related]
7. Conjoint occurrence of GABAB receptor antibodies in Lambert-Eaton myasthenic syndrome with antibodies to the voltage gated calcium channel.
Dogan Onugoren M; Rauschka H; Bien CG
J Neuroimmunol; 2014 Aug; 273(1-2):115-6. PubMed ID: 24929678
[TBL] [Abstract][Full Text] [Related]
8. Anti-SOX1 antibody-positive paraneoplastic neurological syndrome presenting with Lambert-Eaton myasthenic syndrome and small cell lung cancer: A case report.
Li C; Wang X; Sun L; Deng H; Han Y; Zheng W
Thorac Cancer; 2020 Feb; 11(2):465-469. PubMed ID: 31880403
[TBL] [Abstract][Full Text] [Related]
9. Onco-neural antibodies and tumour type determine survival and neurological symptoms in paraneoplastic neurological syndromes with Hu or CV2/CRMP5 antibodies.
Honnorat J; Cartalat-Carel S; Ricard D; Camdessanche JP; Carpentier AF; Rogemond V; Chapuis F; Aguera M; Decullier E; Duchemin AM; Graus F; Antoine JC
J Neurol Neurosurg Psychiatry; 2009 Apr; 80(4):412-6. PubMed ID: 18931014
[TBL] [Abstract][Full Text] [Related]
10. Long-term observation of incremental response and antibodies to voltage-gated calcium channels in patients with Lambert-Eaton myasthenic syndrome: two case reports.
Schneider I; Kornhuber ME; Hanisch F
J Med Case Rep; 2015 Mar; 9():59. PubMed ID: 25885033
[TBL] [Abstract][Full Text] [Related]
11. [Case of anti P/Q type VGCC antibody positive small lung cell carcinoma that occured with subacute cerebellar degeneration, Lambert-Eaton myasthenic syndrome, and brainstem encephalitis].
Nagayama S; Koike F; Sakai T; Antoku Y; Yukitake M; Kuroda Y
Brain Nerve; 2008 Dec; 60(12):1470-4. PubMed ID: 19110759
[TBL] [Abstract][Full Text] [Related]
12. Sequential fluctuating paraneoplastic ocular flutter-opsoclonus-myoclonus syndrome and Lambert-Eaton myasthenic syndrome in small-cell lung cancer.
Simister RJ; Ng K; Lang B; Beckles M; Chao D; McCabe DJ
J Neurol Neurosurg Psychiatry; 2011 Mar; 82(3):344-6. PubMed ID: 20392978
[TBL] [Abstract][Full Text] [Related]
13. Neuronal antibody detection and improved lung cancer prediction in Lambert-Eaton myasthenic syndrome.
Maddison P; Gozzard P; Sadalage G; Ambrose PA; Chapman CJ; Murray A; Thomsen S; Berretta A; Lang B
J Neuroimmunol; 2020 Mar; 340():577149. PubMed ID: 31951874
[TBL] [Abstract][Full Text] [Related]
14. Coexistence of myasthenia gravis and Lambert-Eaton myasthenic syndrome in a small cell lung cancer patient: A case report.
Jia R; Chen J; Ge R; Zheng Q; Chen F; Zhao Z
Medicine (Baltimore); 2018 Jun; 97(23):e10976. PubMed ID: 29879051
[TBL] [Abstract][Full Text] [Related]
15. Chronic multiple paraneoplastic syndromes.
Kleopa KA; Teener JW; Scherer SS; Galetta SL; Bird SJ
Muscle Nerve; 2000 Nov; 23(11):1767-72. PubMed ID: 11054759
[TBL] [Abstract][Full Text] [Related]
16. Lambert-Eaton Myasthenic Syndrome Recurrence Induced by Pembrolizumab in a Patient with Non-small-cell Lung Cancer.
Takigawa Y; Watanabe H; Omote Y; Kurihara S; Inoue T; Fujiwara M; Mitsumune S; Onishi K; Kudo K; Sato A; Sato K; Fujiwara K; Shibayama T
Intern Med; 2023 Apr; 62(7):1055-1058. PubMed ID: 36047125
[TBL] [Abstract][Full Text] [Related]
17. Use of intravenous immunoglobulin in Lambert-Eaton myasthenic syndrome.
Peterlin BL; Flood W; Kothari MJ
J Am Osteopath Assoc; 2002 Dec; 102(12):682-4. PubMed ID: 12501987
[TBL] [Abstract][Full Text] [Related]
18. Paraneoplastic Cerebellar Degeneration and Lambert-Eaton Myasthenic Syndrome with SOX-1 Antibodies.
Wada S; Kamei M; Uehara N; Tsuzaki K; Hamano T
Intern Med; 2021 May; 60(10):1607-1610. PubMed ID: 33328403
[TBL] [Abstract][Full Text] [Related]
19. [Long-term survival case of small-cell lung cancer with Lambert-Eaton myasthenic syndrome without anticancer therapy].
Nakamur S; Kawagishi Y; Kato S; Tsuji H; Takagawa K; Fukuoka J
Nihon Kokyuki Gakkai Zasshi; 2010 Dec; 48(12):918-22. PubMed ID: 21226298
[TBL] [Abstract][Full Text] [Related]
20. Treatment for Lambert-Eaton myasthenic syndrome.
Maddison P; Newsom-Davis J
Cochrane Database Syst Rev; 2003; (2):CD003279. PubMed ID: 12804456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
